DB Financial Investment, Sale of 3 Types Including DLB, ELB, and ELS
[Asia Economy Reporter Ji-hwan Park] DB Financial Investment announced on the 8th that it will sell three types of products: other derivative-linked bonds (DLB), equity-linked bonds (ELB) until the 10th, and equity-linked securities (ELS) until the 17th.
The 3-month maturity product "My First DB DLB No. 125," sold until the 10th, offers a pre-tax annual return of 2.71% if the final bid yield of the underlying asset, a 91-day CD, is 10% or higher at maturity evaluation. Even if it is below 10%, a pre-tax annual return of 2.70% is paid. The minimum subscription amount is 10 million KRW, and subscriptions can be made in units of 1 million KRW.
The "DB Safe No. 681 ELB," based on the KOSPI200 index, is a 1-year maturity product. If during the evaluation period the closing price of the underlying asset, the KOSPI200 index, never exceeds 115% of the initial reference price and the maturity evaluation price of the underlying asset is between 100% and 115% of the initial reference price, a maximum return of 4.25% is possible. If the price has exceeded 115% at any time or the maturity evaluation price is 100% or less, a return of 2.00% is paid.
Hot Picks Today
Dramatic Agreement Reached on Eve of Samsung Electronics General Strike... Minister Kim Young-hoon: "Showcased Korea's Strength in Dialogue" (Update)
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Need to Discuss Excluding Controlling Shareholders' Voting Rights in Dual Listings"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Additionally, an ELS product based on the KOSPI200 Leverage index will be sold until the 17th. Subscriptions are available at all DB Financial Investment branches, on the website, and via the mobile app.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.